Where are products with an unreasonable risk of injury distributed according to CPSA findings?

Where are products with an unreasonable risk of injury distributed according to CPSA findings?

• A. In commerce
• B. In domestic only
• C. In foreign markets only
• D. In private sales

Answer: (A)

The important idea here is understanding what CPSA considers as the scope of distribution. Under the Consumer Product Safety Act, actions target products that move through the market—the channels of commerce. This includes products sold through normal business channels and also those imported into the United States. If a product has an unreasonable risk of injury and is distributed in commerce, CPSA can address it. Private sales or distributions that occur outside those established market channels aren’t within the act’s typical reach. That’s why “in commerce” is the best answer: it captures the broad reach of CPSA to products entering the market, including imports, rather than limiting to domestic-only distribution, foreign markets only, or private sales.

The important idea here is understanding what CPSA considers as the scope of distribution. Under the Consumer Product Safety Act, actions target products that move through the market—the channels of commerce. This includes products sold through normal business channels and also those imported into the United States. If a product has an unreasonable risk of injury and is distributed in commerce, CPSA can address it. Private sales or distributions that occur outside those established market channels aren’t within the act’s typical reach.

That’s why “in commerce” is the best answer: it captures the broad reach of CPSA to products entering the market, including imports, rather than limiting to domestic-only distribution, foreign markets only, or private sales.